Lancet Child Adolesc Health 9:297305 Argente J, Verge CF, Okorie U et al (2025) Setmelanotide in patients aged 25 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial
The SURPASS-2 trial showed Mounjaro 15 mg produced nearly twice the weight loss of Ozempic 1 mg in people with type 2 diabetes
Identification of biomarkers of adrenocortical carcinoma using genomewide gene expression profiling
Temperature fluctuations degrade the compound quickly
During eating windows, follow these guidelines: Consume whole foods rich in nutrients, like fruits, vegetables, lean proteins, and whole grains
Recommended treatment 1-2 times per week